Crispr Therapeutics Ag (CRSP)

Net Change in Cash

$90.49M

TTM · Period ending: · USD

CRSP logo

CRSP Net Change in Cash

Latest reported$90.49M
CRSP TTM Net Change in Cash ($155.02M → $90.49M)
High-resolution chart · PNG

CRSP net change in cash history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Net Change in Cash — Trailing twelve months (TTM) (USD)
Period endingNet Change in Cash (USD)
90,489,000
180,895,000
49,302,000
60,827,000
-290,854,000
-472,240,000
-91,292,000
-302,166,000
39,605,000
362,945,000
177,592,000
33,614,000
-52,097,000
-340,229,000
-711,876,000
-518,127,000
-1,150,483,000
-440,926,000
-244,366,000
-28,643,000
713,346,000
248,150,000
236,656,000
424,630,000
519,571,000
454,041,000
489,000,000
143,172,000
108,898,000
95,780,000
216,900,000
233,787,000
47,484,000
52,906,000
-75,762,000
24,906,000
25,415,000
88,272,000
159,559,000
179,564,000
192,178,000
195,972,000
155,016,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.